Anti-Coagulant Injection Treats Heparin-Induced Thrombocytopenia

 

March 30, 2010

The anti-coagulant Argatroban injection, 100mg/mL, is indicated as an anti-coagulant for prophylaxis or treatment of thrombosis in patients with heparin-induced thrombocytopenia. It is also used as an anticoagulant in patients with or at risk for heparin-induced thrombocytopenia undergoing percutaneous coronary intervention (PCI).

The anti-coagulant effects begin immediately after infection. The drug is a synthetic direct thrombin inhibitor that does not interact with heparin anti-bodies.

For more information: www.argatroban.com, www.tevapharm.com